Chiba Refractory Schizophrenia Treatment-LAI study
Not Applicable
- Conditions
- schizophrenia,schizoaffective disorder
- Registration Number
- JPRN-UMIN000008487
- Lead Sponsor
- Department of Psychiatry, Graduate School of Medicine, Chiba University
- Brief Summary
Of the 43 TRS patients at the 6 months observational period following risperidone long-acting injection initiation, 25 (58%) patients were diagnosed as DSP.Following 6 months of RLAI treatment, 17 of these 25 DSP patients (68%) had responded to RLAI.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have already received risperidone long- acting injection.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Brief Psychiatric Rating Scale
- Secondary Outcome Measures
Name Time Method